Molecule Details
InChIKeyDOPFAJXYFJSQLF-OJCNQGKOSA-N
Compound Name(3R,5S,8S,14R,17E)-8-cyclohexyl-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-24-ethoxy-20-methoxy-7,10-dioxo-2,15-dioxa-6,9,11,23-tetrazapentacyclo[17.6.2.13,6.111,14.022,26]nonacosa-1(25),17,19(27),20,22(26),23-hexaene-5-carboxamide
Canonical SMILESC=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H]2CN1C(=O)[C@H](C1CCCCC1)NC(=O)N1CC[C@H](C1)OC/C=C/c1cc3c(cc(OCC)nc3cc1OC)O2)C(=O)NS(=O)(=O)C1CC1
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)3
Pfam Stratification Cross-Family
Avg pChEMBL8.93
SourceChEMBL;BindingDB
2D Structure
2D structure
Activity Profile
Target Activities (3)
Target Gene Organism Category Pfam pChEMBL Type Source
A3EZI9 NS3 Hepacivirus hominis Pathogen PF07652 PF22027 PF02907 9.5 Ki ChEMBL
D2K2A8 NS4A Hepacivirus hominis Pathogen PF01006 9.5 Ki ChEMBL
K7XJL6 Hepacivirus hominis Pathogen PF07652 PF01006 PF22027 PF02907 7.7 Ki ChEMBL;BindingDB